boosh meaning

8,000 plus Attend Boosh Sponsored Planted Expo in Vancouver

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company") is proud to announce that over 8,000 consumers and investors visited the largest plant-based expo in Canada; Planted-Expo at which Boosh was the presenting sponsor. At the event Boosh proudly introduced its brand-new shelf stable line of Boosh Mac & Cheeze; Nacho and Better Cheddar to rave reviews, and provided samples to consumers of Boosh's favourite foods including Shephard's Pie, and recently acquired brands such as Salt Spring Harvest pate and Pulse Specialty Kitchen plant-based cheeses.


"We were ecstatic that literally thousands of people stopped by our booth and sampled our wonderful variety of plant-based cheeses, entrees and meals. We also added over 800 social media followers and sold thousands of dollars of products from our Booth. By the end of the event we had even sold out of the Mac & Cheeze lines," states Connie Marples founder and president of Boosh.

"This was an excellent opportunity to meet over one hundred local shareholders and investors in a casual setting, share stories and sample all types of Boosh products," states Jim Pakulis CEO of Boosh. "Just as importantly, management was also able to introduce Boosh to buyers in the food service industry such as the restaurant and bar sectors. In short, the event was a huge success for Team Boosh!"

In other news TJ Walsh, Boosh's newly hired VP of Sales North America, commenced work on Monday. TJ is responsible for all sales strategy, development, direction and budget. He will be developing on-site sales training and policy formulation, and will report directly to the president, Connie Marples, and CEO Jim Pakulis. TJ has extensive sales experience including, but not limited, to National Director of Sales for Silver Hills, a plant-based bakery and organic foods company. Prior to that, he was Sales Manager for UNFI, North America's largest all natural and organic distributor. Previously, he spent eight years with Bolthouse Farms, eventually being promoted to Director of Field Sales. At Bolthouse Farms, he was responsible for implementing a multi-million dollar sales budget, overseeing 30 sales representatives, developing strategic growth plans for selling all new product lines, and creating merchandising and sales strategies for Walmart, Kroger, Target, Safeway/Albertsons, HEB, Loblaws, Save On, Kroger's and Whole Foods.

The board of directors extended CEO Jim Pakulis' consulting agreement for one year of services. In exchange, the Company will provide Jim with 250,00 warrants priced at $2.00 and an exercise period of four years, and fifty thousand dollars.

"I'm committed to lead Boosh for the long run, however long that takes. Equally important, I'm committed to building our infrastructure, seek out key acquisitions and expand Boosh throughout North America. My personal belief is a two dollar exercise price for the warrants offered to me is fair and equitable based on where I believe the company is heading," states Jim Pakulis.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (833) 882-6674

www.Booshfood.com

About Boosh Plant-Based Brands Inc.:

Boosh Plant-Based Brands Inc., through its wholly owned subsidiary, Boosh Food (www.booshfood.com), offers high quality, non-GMO, gluten free, 100% plant-based nutritional comfort foods for the whole family. We currently offer six frozen meals and three refrigerated meals which are sold throughout Canada. Boosh, good for you and good for planet earth.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the Company's proposed use of the proceeds of its initial public offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105169

News Provided by Newsfile via QuoteMedia

The Conversation (0)
The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

Cleo Diagnostics (COV:AU) has announced The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

Download the PDF here.

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY

MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight

MariTide is the First Obesity Treatment With Monthly or Less Frequent Dosing to Demonstrate Safe and Effective Weight Loss in a Phase 2 Study

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM

Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 5 a.m. PT on Tuesday, Nov. 26, 2024 to discuss data from the 52-week, Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133) and progress on its development program. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
  BPH Global Ltd

Seaweed Consultancy Renewed – Focus on Blockchain, Carbon Credits and AI to Drive R&D Program

The Board of BPH Global Ltd (ASX: BP8) (Company), is pleased to advise the re-appointment of Gaia Mariculture Pte Ltd (Gaia Mariculture) as the manager of the Company’s research and development programs (R&D Programs). Pursuant to the renewed consulting agreement, the Company’s wholly owned, Singapore-based subsidiary Stemcell United Pte Ltd (BP8 Singapore) has engaged Gaia Mariculture as a to manage the BP8 Group’s R&D Programs (Consulting Agreement).

Keep reading...Show less
Sirona Biochem (TSXV:SBM)

Sirona Biochem


Keep reading...Show less

Latest Press Releases

Related News

×